Barclays’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-19,907
| Closed | -$1.93M | – | 4370 |
|
|
2015
Q1 | $1.93M | Buy |
19,907
+17,771
| +832% | +$1.72M | ﹤0.01% | 1283 |
|
|
2014
Q4 | $196K | Sell |
2,136
-2,584
| -55% | -$237K | ﹤0.01% | 2378 |
|
|
2014
Q3 | $321K | Sell |
4,720
-5,384
| -53% | -$366K | ﹤0.01% | 2126 |
|
|
2014
Q2 | $1.05M | Buy |
10,104
+3,955
| +64% | +$411K | ﹤0.01% | 1677 |
|
|
2014
Q1 | $504K | Sell |
6,149
-1,866
| -23% | -$153K | ﹤0.01% | 1986 |
|
|
2013
Q4 | $514K | Sell |
8,015
-1,782
| -18% | -$114K | ﹤0.01% | 2132 |
|
|
2013
Q3 | $617K | Buy |
9,797
+7,522
| +331% | +$474K | ﹤0.01% | 2001 |
|
|
2013
Q2 | $95K | Buy |
+2,275
| New | +$95K | ﹤0.01% | 3055 |
|